- Home
- GROY vs DRTS Comparison
GROY vs DRTS Comparison
Compare GROY & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- DRTS
- Stock Information
- Founded
- GROY 2020
- DRTS 2015
- Country
- GROY Canada
- DRTS Israel
- Employees
- GROY N/A
- DRTS N/A
- Industry
- GROY
- DRTS Medical/Dental Instruments
- Sector
- GROY
- DRTS Health Care
- Exchange
- GROY Nasdaq
- DRTS Nasdaq
- Market Cap
- GROY 322.2M
- DRTS 274.0M
- IPO Year
- GROY 2021
- DRTS N/A
- Fundamental
- Price
- GROY $2.68
- DRTS $3.02
- Analyst Decision
- GROY Strong Buy
- DRTS Strong Buy
- Analyst Count
- GROY 3
- DRTS 2
- Target Price
- GROY $3.67
- DRTS $8.00
- AVG Volume (30 Days)
- GROY 1.6M
- DRTS 40.5K
- Earning Date
- GROY 08-12-2025
- DRTS 08-13-2025
- Dividend Yield
- GROY N/A
- DRTS N/A
- EPS Growth
- GROY N/A
- DRTS N/A
- EPS
- GROY N/A
- DRTS N/A
- Revenue
- GROY $10,347,000.00
- DRTS N/A
- Revenue This Year
- GROY $84.26
- DRTS N/A
- Revenue Next Year
- GROY $50.03
- DRTS N/A
- P/E Ratio
- GROY N/A
- DRTS N/A
- Revenue Growth
- GROY 99.94
- DRTS N/A
- 52 Week Low
- GROY $1.16
- DRTS $1.93
- 52 Week High
- GROY $2.75
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- GROY 62.89
- DRTS 48.72
- Support Level
- GROY $2.52
- DRTS $2.95
- Resistance Level
- GROY $2.75
- DRTS $3.07
- Average True Range (ATR)
- GROY 0.11
- DRTS 0.13
- MACD
- GROY -0.00
- DRTS -0.01
- Stochastic Oscillator
- GROY 79.63
- DRTS 33.72
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.